mitomycin has been researched along with nystatin a1 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lorimer, SD; Perry, NB; Tangney, RS | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| BRUNNER, R | 1 |
2 review(s) available for mitomycin and nystatin a1
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[RECENT DEVELOPMENTS IN THE FIELD OF ANTIBIOTICS (III)].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antineoplastic Agents; Azaserine; Carboxylic Acids; Cyclopentanes; Dactinomycin; Griseofulvin; Leucine; Mitomycin; Mitomycins; Nystatin; Puromycin | 1963 |
2 other study(ies) available for mitomycin and nystatin a1
| Article | Year |
|---|---|
An antifungal bibenzyl from the New Zealand liverwort, Plagiochila stephensoniana. Bioactivity-directed isolation, synthesis, and analysis.
Topics: Anisoles; Antifungal Agents; Antiviral Agents; Bacteria; Bibenzyls; Fungi; Microbial Sensitivity Tests; New Zealand; Phenols; Plants, Medicinal | 1993 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |